A Flagship VentureLabs Company

BG Medicine, Inc.

880 Winter Street
Suite 210

Waltham, MA  02451

Tel: 781.890.1199


Leadership:
Paul Sohmer, M.D.
President & CEO


Website:
www.bg-medicine.com

BG Medicine, Inc.

Flagship Partners:  Noubar Afeyan
Initial Investment: 
2000
Status: 
Public

BG Medicine (NASDAQ: BGMD) is a publicly traded developer of the BGM Galectin-3® Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.

Noubar Afeyan is on the Board of Directors and Stéphane Bancel is Executive Chairman of the Board.